Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat ...

NVO's first-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially ...

The use of tablets as a tool for entertainment, work, and communication is on the rise. However, using a tablet while driving is not advisable as it can be hazardous and distracting. Car mounts ...

Ozempic isn't FDA approved to help with weight loss, but other drugs containing GLP-1 receptor agonists - like semaglutide (Wegovy ... There is a GLP-1 pill on the market now called Rybelsus, however ...

We've reviewed plenty of Android and iPad tablets, but the best rugged tablets are the ones built for the real-world - whether you're working in hostile environments or out camping and hiking.

That came in response to a February lawsuit from a compounding trade group against the Food and Drug Administration's determination that the active ingredient in those drugs, semaglutide ...

"We are deeply disappointed that the (court) misapprehended or failed to take into consideration the clear and convincing evidence that demonstrates that the manufactured supply of semaglutide is ...

If you're looking for a larger canvas for reading, sketching, gaming, or just about anything else, you're likely much better off going with a tablet. This lets your smartphone keep doing what it ...

70. Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy.